Due to its high selectivity, potency and safety, CHMFL-BTK-11 will be a preferred pharmacological tool for dissection of BTK mediated signaling pathway in the autoimmune diseases and a variety of cancers. This evidence concerns the gene BTK and autoimmune disease.